Melrose shares drop 12% as guidance disappoints despite strong cash flow beat

Melrose shares plunged ~12% to 564p after management guided 2026 EBIT of £700m–£750m, below prior consensus of ~£754m, with Airframes (rebranded Structures) the weak spot at £170m–£190m versus a £210m consensus due to lower business-jet volumes and Dutch-site productivity issues. Second-half EBIT of £337m was 1% ahead of estimates and second-half free cash flow beat by 18% at £179m (full-year FCF £125m), though ~£59m of the cash flow was receivable factoring (balance sheet receivables rose £338m→£396m). The company announced a £175m buyback; brokers are split (Peel Hunt 830p buy, UBS 430p sell), leaving investor sentiment negative despite the cash-flow beat.

Analysis

Market structure: Melrose (LSE:MRO) weakness re-rates a structures-first narrative: Engines remain resilient (guidance £565-595m) so engine-supply chains, MRO services and aftermarket parts (higher margin) are relative winners while business-jet focused airframe suppliers and Dutch-site contractors are losers. The £175m buyback and 12% intraday drop compress free-float and raise short-term liquidity support, but lower Airframes guidance (£170-190m vs £210m consensus) signals near-term pricing pressure and inventory digestion in structures.

Risk assessment: Near-term tail risks include prolonged Dutch productivity problems, a reversal of receivable factoring (currently +£59m to £396m) and potential covenant strain if buybacks are debt-funded; a >£400m factoring level or a cut to 2026 guidance below £700m would be material. Timeline: days—heightened volatility and option skew; weeks—analyst revisions and buyback execution; quarters—EBITDA multiple re-rating toward peers if Airframes recovers or further downgrades arrive.

Trade implications: Two plausible, sized strategies: a contrarian, capped long in MRO targeting Peel Hunt’s 830p (12-month) and a tactical short if operational headlines worsen to sub-500p (target UBS 430p). Use options to define risk: buy Jan-2027 call spreads to play re-rating (600p/900p) or buy Jun-2026 put spreads (500p/400p) to express downside; hedge sector beta via short FTSE aerospace exposure (e.g., ITA) for 50–75% notional.

Contrarian angles: The market may be over-penalising a modest EBIT miss (gap ~£4–54m vs consensus) while engines drive most profit; factoring masks some cash quality but the FCF beat (£125m) clears a £100m psychological barrier. If Airframes productivity is fixed within 3–6 months and buyback is >£100m deployed quickly, a technical squeeze and re-rating from ~11x to closer to peer 14–15x EBITDA is plausible; conversely, stretched cash conversion would derail that upside.

Key Decisions for Investors

• Establish a 2–3% long position in Melrose (LSE:MRO) if price trades below 600p; add to 3–4% if price falls <500p. Target 830p in 9–12 months (Peel Hunt), hard stop 480p to cap downside and reassess if receivable factoring >£400m or Airframes guidance is cut below £170m.
• If seeking defined-risk upside, buy Jan-2027 MRO call spread 600p/900p sized to equal a 1–2% portfolio exposure (max risk = premium). Rationale: limited cost to capture re-rating toward peer 14–15x EBITDA if Airframes recovers within 6–12 months.
• If conviction turns negative on execution, initiate a 2% short at break below 500p with target 430p (UBS PT) and stop 580p; pair by going long 50–75% notional of FTSE/global aerospace ETF (e.g., ITA) to isolate company-specific downside.
• Monitor three near-term triggers (action thresholds within 30–90 days): receivable factoring >£400m (sell/trim), buyback execution >£100m deployed (buy/hold), and any downward revision to Airframes 2026 EBIT guidance <£170m (increase short sizing or widen put protection).